Method for the treatment of renal cell carcinoma

Details Method for the treatment of renal cell carcinoma Method for the treatment of renal cell carcinoma

1989-02-13

1991-02-19

Lee, Lester L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530322, A61K 3702

Patent

active

049944401

ABSTRACT:
The present invention relates to a method for the treatment of renal cell carcinoma comprising administering to a warm blooded mammal in need thereof a therapeutically effective amount of N-acetylmuramyl-L-alanyl-D-isogutamin-yl-L-alanine-2-(1,2-dipalmitoyl-sn-g lyc ro-3-hydroxyphosphoryloxy)ethylamide monosodium salt preferably encapsulated in a multilamellar liposomal composition comprising phosphatidylcholine and phosphatidylserine.

REFERENCES:
patent: 4548923 (1985-10-01), Hartmann et al.
patent: 4619794 (1986-10-01), Hanser
patent: 4738843 (1988-04-01), Oguchi et al.
patent: 4774085 (1988-09-01), Fidler
Creaven et al., Liposomes in the Therapy of Infectious Diseases and Cancer, pp. 297-303 (1989).
Comprehensive Textbook of Oncology, pp. 889-900, Williams and Wilkins, Baltimore (1986).
J. Of Urology, 117, pp. 272-275 (1977).
Cancer Principles & Practice of Oncology, 3rd Ed., (1989), p. 991.

Affiliated with

Also associated with

Rating

Method for the treatment of renal cell carcinoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the treatment of renal cell carcinoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of renal cell carcinoma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1143667